NCT04765150 Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
| NCT ID | NCT04765150 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jonsson Comprehensive Cancer Center |
| Condition | Prostate Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 275 participants |
| Start Date | 2021-04-01 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 275 participants in total. It began in 2021-04-01 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates how new magnetic resonance imaging (MRI) and artificial intelligence techniques improve the image quality and quantitative information for future prostate MRI exams in patients with suspicious of confirmed prostate cancer. The MRI and artificial intelligence techniques developed in this study may improve the accuracy in diagnosing prostate cancer in the future using less invasive techniques than what is currently used.
Eligibility Criteria
Inclusion Criteria: * Male patients 18 years of age and older * Clinical suspicion of prostate cancer or biopsy-confirmed prostate cancer * Undergone or undergoing multi-parametric 3 T prostate MRI at the University of California at Los Angeles (UCLA) * Ability to provide consent Exclusion Criteria: * Contraindications to MRI (e.g., cardiac devices, prosthetic valves, severe claustrophobia) * Contraindications to gadolinium contrast-based agents other than the possibility of an allergic reaction to the gadolinium contrast-based agent * Prior radiotherapy
Contact & Investigator
Kyung H Sung, PhD
PRINCIPAL INVESTIGATOR
UCLA / Jonsson Comprehensive Cancer Center
Frequently Asked Questions
Who can join the NCT04765150 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04765150 currently recruiting?
Yes, NCT04765150 is actively recruiting participants. Contact the research team at nbarroso@mednet.ucla.edu for enrollment information.
Where is the NCT04765150 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT04765150 clinical trial?
NCT04765150 is sponsored by Jonsson Comprehensive Cancer Center. The principal investigator is Kyung H Sung, PhD at UCLA / Jonsson Comprehensive Cancer Center. The trial plans to enroll 275 participants.